McKesson Corp (MCK) stock
MCKNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3027% above fair value
$1084.43−7.24 (-0.66%)
Close on Nov 18, 2026Market cap $126.43BP/E 29.0Yield 0.29%
McKesson revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
McKesson's revenue for the twelve months ending Jun 30, 2026 was $410.98B, up 8.8% year over year. For fiscal 2026 it was $403.43B, up 12.4% from the year before. Over ten years it grew 7.8% a year on average. The highest annual figure on record is $403.43B in fiscal 2026.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $403.43B | +12.4% |
| FY2025 | Mar 31, 2025 | $359.05B | +16.2% |
| FY2024 | Mar 31, 2024 | $308.95B | +11.7% |
| FY2023 | Mar 31, 2023 | $276.71B | +4.8% |
| FY2022 | Mar 31, 2022 | $263.97B | +10.8% |
| FY2021 | Mar 31, 2021 | $238.23B | +3.1% |
| FY2020 | Mar 31, 2020 | $231.05B | +7.8% |
| FY2019 | Mar 31, 2019 | $214.32B | +2.9% |
| FY2018 | Mar 31, 2018 | $208.36B | +4.9% |
| FY2017 | Mar 31, 2017 | $198.53B | +4.0% |
| FY2016 | Mar 31, 2016 | $190.88B | +6.6% |
| FY2015 | Mar 31, 2015 | $179.05B | +30.3% |
| FY2014 | Mar 31, 2014 | $137.39B | +12.4% |
| FY2013 | Mar 31, 2013 | $122.20B | -0.1% |
| FY2012 | Mar 31, 2012 | $122.32B | +9.1% |
| FY2011 | Mar 31, 2011 | $112.08B | +3.1% |
| FY2010 | Mar 31, 2010 | $108.70B | +1.9% |
| FY2009 | Mar 31, 2009 | $106.63B | +4.8% |
| FY2008 | Mar 31, 2008 | $101.70B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $105.38B | +7.7% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $96.30B | +6.0% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $106.16B | +11.4% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $103.15B | +10.1% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $97.83B | +23.4% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $90.82B | +18.9% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $95.29B | +17.8% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $93.65B | +21.3% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $79.28B | +6.4% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $76.36B | +10.8% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $80.90B | +14.8% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $77.22B | +10.1% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $74.48B | +10.9% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $68.91B | +4.2% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $70.49B | +2.7% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $70.16B | +5.4% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $67.15B | +7.1% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $66.10B | +11.8% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $68.61B | +9.6% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $66.58B | +9.5% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $62.67B | +12.6% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $59.14B | +1.0% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $62.60B | +5.8% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $60.81B | +5.5% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $55.68B | -0.1% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $58.54B | +11.6% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $59.17B | +5.3% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $57.62B | +8.6% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $55.73B | +5.9% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $52.43B | +1.6% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $56.21B | +4.8% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $53.08B | +1.9% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $52.61B | +3.0% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $51.63B | +6.0% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $53.62B | +7.0% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $52.06B | +4.2% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $51.05B | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $48.71B | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $50.13B | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $49.96B | – |
See a number that looks wrong?